- Home
- COCH vs PAVM Comparison
COCH vs PAVM Comparison
Compare COCH & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COCH | PAVM |
|---|---|---|
| Founded | 1995 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.0M | 41.1M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | COCH | PAVM |
|---|---|---|
| Price | $0.70 | $3.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.00 | ★ $65.00 |
| AVG Volume (30 Days) | ★ 50.5K | 24.7K |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.45 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $241,000.00 | ★ $3,000,000.00 |
| Revenue This Year | $1.58 | $603.94 |
| Revenue Next Year | N/A | $33.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 7.11 | ★ 20.00 |
| 52 Week Low | $0.36 | $0.21 |
| 52 Week High | $1.89 | $28.44 |
Technical Indicators
Market Signals| Indicator | COCH | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 46.24 | 43.60 |
| Support Level | $0.63 | $3.78 |
| Resistance Level | $0.74 | $6.56 |
| Average True Range (ATR) | 0.03 | 0.37 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 32.11 | 35.62 |
Price Performance
Historical ComparisonAbout COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.